Generic Testing of Antigen Tests for COVID-19 in Denmark
NCT04913116 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2022-01-26
Summary
To evaluate the analytical and clinical sensitivity and specificity of antigen tests performed as oropharyngeal swabs, outer nasal swabs, saliva swabs or breath tests including self-tests for SARS-CoV-2 towards standard RT-PCR testing.
For each test 200 SARS-CoV-2 positive and 200 SARS-CoV-2 negative individuals previously defined by RT-PCR are tested. When tested an additional RT-PCR test is performed to verify status.
Analytical sensitivity and specificity is determined on 210 SARS-CoV-2 positive samples with known Cq and 100 SARS-CoV-2 negative samples.
30 companies with a total of 55 tests participate in this nationwide study.
Conditions
- SARS-CoV2 Infection
- COVID-19 Testing
Interventions
- DIAGNOSTIC_TEST
-
Comparison of antigen tests with RT-PCR as reference method
Antigen tests are performed locally including sampling from multiple anatomical testing sites. A reference oropharyngeal swab is always send for RT-PCR for SARS-CoV-2 at DTU to verify the status of the patient. RT-PCR samples from other anatomical test locations may be included.
Sponsors & Collaborators
-
Aalborg University Hospital
collaborator OTHER -
Herlev and Gentofte Hospital
collaborator OTHER -
Odense University Hospital
collaborator OTHER -
Aarhus University Hospital
collaborator OTHER -
Rigshospitalet, Denmark
collaborator OTHER -
Slagelse Hospital
collaborator OTHER -
Esbjerg Hospital - University Hospital of Southern Denmark
collaborator OTHER -
Sygehus Lillebaelt
collaborator OTHER -
Statens Serum Institut
collaborator OTHER -
Hvidovre University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-18
- Primary Completion
- 2021-09-09
- Completion
- 2021-09-09
Countries
- Denmark
Study Locations
More Related Trials
-
Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test
NCT04609969 ·Status: COMPLETED ·Phase: NA
-
Comparison of Detection of SARS-CoV2 (COVID-19) Between Nasopharyngeal Swab Specimens and Those Obtained by Salivary Sputum
NCT05024461 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).
NCT04859023 ·Status: COMPLETED ·Phase: NA
-
Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs
NCT04840082 ·Status: COMPLETED ·Phase: NA
-
Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals
NCT04321369 ·Status: COMPLETED
-
A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research
NCT04327804 ·Status: COMPLETED
-
Self-sampling for the Study of COVID-19
NCT04447495 ·Status: COMPLETED
-
Antigen Rapid Test Screening to Prevent SARS-CoV-2 Transmission (COVID-19) at Mass Gathering Events.
NCT04898127 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen
NCT04733170 ·Status: UNKNOWN
-
Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19.
NCT04839094 ·Status: COMPLETED
-
Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR
NCT04361448 ·Status: TERMINATED ·Phase: NA
-
Assessment of Self-Collected Sample Compared to Clinician Collected Sample in COVID-19 and Influenza Program
NCT04681950 ·Status: UNKNOWN
-
Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva
NCT04578509 ·Status: COMPLETED
-
SARS-CoV-2 OTC At Home Test
NCT05553964 ·Status: TERMINATED ·Phase: NA
-
A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production
NCT03198676 ·Status: COMPLETED ·Phase: PHASE1
-
Saliva as Source of Detection for SARS-CoV-2
NCT04424446 ·Status: COMPLETED
-
Evaluation of the Diagnostic Performance of the TestNPass DM-DIV for SARS-CoV-2 Using a Nasopharyngeal Sample
NCT06917261 ·Status: COMPLETED ·Phase: NA
-
Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients
NCT04590352 ·Status: COMPLETED
-
Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males
NCT04391829 ·Status: UNKNOWN ·Phase: NA
-
Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR
NCT04604145 ·Status: COMPLETED ·Phase: NA
-
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
NCT05864118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
COVID-19 Testing Sample Acquisition Throughput and Efficiency
NCT04532411 ·Status: COMPLETED
-
Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19)
NCT04513990 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19
NCT04510454 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the SONA Saliva C-19 Rapid Self-Test for the Detection of COVID-19
NCT05256589 ·Status: COMPLETED ·Phase: NA